The Pertussis vaccine, commonly administered as part of the DTaP or Tdap vaccines, is designed to protect against Bordetella pertussis, the bacterium causing whooping cough. Pertussis is a highly contagious respiratory infection known for severe coughing fits, particularly dangerous for infants who may experience life-threatening complications. The vaccine induces an immune response, leading to the production of antibodies that target the pertussis bacteria. In addition to pertussis, the DTaP vaccine also provides protection against diphtheria and tetanus. Immunization typically begins in infancy with a series of DTaP doses, followed by booster shots in childhood and adolescence. The Tdap vaccine is recommended for adolescents and adults to maintain immunity. Pertussis vaccination has significantly reduced the incidence of whooping cough and its associated complications. However, periodic boosters are crucial for sustaining immunity and preventing outbreaks. Ongoing research aims to refine pertussis vaccines, enhance their effectiveness, and address challenges like waning immunity to ensure continued protection against this contagious respiratory disease.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan